Biotricity Stock Working Capital
Biotricity fundamentals help investors to digest information that contributes to Biotricity's financial success or failures. It also enables traders to predict the movement of Biotricity Stock. The fundamental analysis module provides a way to measure Biotricity's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotricity stock.
Biotricity |
Biotricity Company Working Capital Analysis
Biotricity's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Biotricity Working Capital | (18.23 M) |
Most of Biotricity's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotricity is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
CompetitionIn accordance with the company's disclosures, Biotricity has a Working Capital of (18.23 Million). This is 104.28% lower than that of the Health Care Equipment & Supplies sector and 101.34% lower than that of the Health Care industry. The working capital for all United States stocks is 101.23% higher than that of the company.
Biotricity Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotricity's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biotricity could also be used in its relative valuation, which is a method of valuing Biotricity by comparing valuation metrics of similar companies.Biotricity is currently under evaluation in working capital category among its peers.
Biotricity Fundamentals
| Return On Equity | -41.01 | ||||
| Return On Asset | -0.89 | ||||
| Profit Margin | (1.17) % | ||||
| Operating Margin | (0.96) % | ||||
| Current Valuation | 38.87 M | ||||
| Shares Outstanding | 21.48 M | ||||
| Shares Owned By Insiders | 48.61 % | ||||
| Shares Owned By Institutions | 1.62 % | ||||
| Number Of Shares Shorted | 459.95 K | ||||
| Price To Earning | (6.70) X | ||||
| Price To Book | 33.02 X | ||||
| Price To Sales | 0.83 X | ||||
| Revenue | 12.06 M | ||||
| Gross Profit | 4.57 M | ||||
| EBITDA | (8.82 M) | ||||
| Net Income | (14.09 M) | ||||
| Cash And Equivalents | 2.89 M | ||||
| Cash Per Share | 0.05 X | ||||
| Total Debt | 23.88 M | ||||
| Debt To Equity | 6.45 % | ||||
| Current Ratio | 1.54 X | ||||
| Book Value Per Share | (3.31) X | ||||
| Cash Flow From Operations | (6.69 M) | ||||
| Short Ratio | 5.50 X | ||||
| Earnings Per Share | (1.66) X | ||||
| Target Price | 4.0 | ||||
| Number Of Employees | 55 | ||||
| Beta | 1.4 | ||||
| Market Capitalization | 10.02 M | ||||
| Total Asset | 5.94 M | ||||
| Retained Earnings | (127.5 M) | ||||
| Working Capital | (18.23 M) | ||||
| Current Asset | 11 K | ||||
| Current Liabilities | 303 K | ||||
| Net Asset | 5.94 M |
About Biotricity Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotricity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotricity using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotricity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Biotricity Stock
If you are still planning to invest in Biotricity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biotricity's history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |